Jun Xue

421 total citations
26 papers, 268 citations indexed

About

Jun Xue is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jun Xue has authored 26 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Jun Xue's work include Cancer-related molecular mechanisms research (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Caveolin-1 and cellular processes (3 papers). Jun Xue is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Caveolin-1 and cellular processes (3 papers). Jun Xue collaborates with scholars based in China, United States and Hong Kong. Jun Xue's co-authors include Yunqiao Li, Likun Wang, Junfeng Liu, Xiaoye Zhu, Chenyu Wang, Jianli Hu, Paul B.S. Lai, George Y. Chen, Fei Guo and Shengli Yang and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Cellular Biochemistry.

In The Last Decade

Jun Xue

22 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Xue China 9 150 89 65 41 37 26 268
Rui Cong China 7 162 1.1× 115 1.3× 47 0.7× 57 1.4× 17 0.5× 11 258
Elina Zorde‐Khvalevsky Israel 8 156 1.0× 146 1.6× 33 0.5× 51 1.2× 38 1.0× 9 309
Xiaojie Gan China 12 143 1.0× 87 1.0× 64 1.0× 55 1.3× 99 2.7× 23 334
Xianxiong Ma China 12 259 1.7× 133 1.5× 75 1.2× 18 0.4× 77 2.1× 26 394
Haifeng Lin China 8 98 0.7× 70 0.8× 108 1.7× 50 1.2× 52 1.4× 32 303
Wei Wen China 11 179 1.2× 127 1.4× 90 1.4× 27 0.7× 39 1.1× 25 350
Xu Fan China 11 124 0.8× 57 0.6× 45 0.7× 89 2.2× 76 2.1× 19 313
Shaohan Wu China 10 190 1.3× 109 1.2× 99 1.5× 30 0.7× 17 0.5× 20 320

Countries citing papers authored by Jun Xue

Since Specialization
Citations

This map shows the geographic impact of Jun Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Xue more than expected).

Fields of papers citing papers by Jun Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Xue. The network helps show where Jun Xue may publish in the future.

Co-authorship network of co-authors of Jun Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Xue. A scholar is included among the top collaborators of Jun Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Xue. Jun Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Qiu, Fang, Xi Gu, Xiaofeng Zheng, et al.. (2024). 276P SHR-A1811 in combination with pyrotinib as neoadjuvant treatment for HER2-positive breast cancer (HER2+ BC): Preliminary results from MUKDEN 07. Annals of Oncology. 35. S331–S331. 3 indexed citations
5.
6.
7.
Zhang, Yue, Jun Xue, Zhisheng Zhang, et al.. (2021). Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2. Bioengineered. 13(1). 455–468. 14 indexed citations
8.
Liu, Junfeng, Lingyun Lai, Jiajia Lin, et al.. (2020). Ranitidine and finasteride inhibit the synthesis and release of trimethylamine N-oxide and mitigates its cardiovascular and renal damage through modulating gut microbiota. International Journal of Biological Sciences. 16(5). 790–802. 27 indexed citations
9.
Yang, Xiaoyan, Jie Jin, Ping Li, et al.. (2020). Expression and clinical significance profile analysis of S100 family members in human acute myeloid leukemia.. PubMed. 24(13). 7324–7334. 7 indexed citations
10.
Ren, Jie, Yong Yang, Jun Xue, et al.. (2019). TSP‐1 is downregulated and inversely correlates with miR‐449c expression in Cushing's disease. Journal of Cellular and Molecular Medicine. 23(6). 4097–4110. 12 indexed citations
11.
Dai, Xiaomeng, Jun Xue, Jianli Hu, et al.. (2017). Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma. Translational Oncology. 10(4). 511–517. 44 indexed citations
12.
Xue, Jun, et al.. (2016). Correlation of RUNX3 expression with microvessel density in colorectal adenocarcinoma tissues and clinical significance. Asian Pacific Journal of Tropical Medicine. 10(1). 98–101. 7 indexed citations
13.
14.
15.
Wang, Hongna, Xiaoye Zhu, Qionghong Xie, et al.. (2015). The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients. Clinical Immunology. 160(2). 342–348. 13 indexed citations
16.
Xue, Jun, et al.. (2015). Correlation of caveolin-1 expression with microlymphatic vessel density in colorectal adenocarcinoma tissues and its correlation with prognosis. Asian Pacific Journal of Tropical Medicine. 8(8). 655–657. 6 indexed citations
17.
Peng, Gang, Rubo Cao, Jun Xue, et al.. (2014). Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma. Radiology and Oncology. 48(1). 40–49. 8 indexed citations
18.
Zhang, Wanli, Jing Huang, Gang Peng, et al.. (2013). Null genotype of glutathione S-transferase T1 contributes to increased risk of gastric cancer in Asian population. Tumor Biology. 34(3). 1461–1466. 5 indexed citations
19.
Liu, Guojing, Weichao Wang, Hui Xie, et al.. (2011). Improved Neuronal Survival of Focal Ischemia After Delipid Extracorporeal Lipoprotein Treatment in Hyperlipidemic Rabbits. Artificial Organs. 35(7). E145–54. 2 indexed citations
20.
Li, Mingxin, Jun Xue, Junfeng Liu, et al.. (2010). Efficacy of Cytokine Removal by Plasmadiafiltration Using a Selective Plasma Separator: In Vitro Sepsis Model. Therapeutic Apheresis and Dialysis. 15(1). 98–108. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rui Cong Breakdown of academic impact, for papers by Elina Zorde‐Khvalevsky Breakdown of academic impact, for papers by Xiaojie Gan Breakdown of academic impact, for papers by Xianxiong Ma Breakdown of academic impact, for papers by Haifeng Lin Breakdown of academic impact, for papers by Wei Wen Breakdown of academic impact, for papers by Xu Fan Breakdown of academic impact, for papers by Shaohan Wu
Rankless by CCL
2026